Search Results - "Kazeem, Benga"

Identification of characteristics associated with long-term survival in patients with metastatic urothelial carcinoma (mUC) who received durvalumab (D) with or without tremelimumab (T) in clinical studies by Alt, Marie, Stecca, Carlos, Kabadi, Shaum, Kazeem, Benga, Sridhar, Srikala S.

“…Abstract only 441 Background: Immune checkpoint inhibitors (ICI) have changed the landscape of mUC, yet outcomes are variable as some patients (pts) do not…”
Get full text

P-396 Characterization and Management of Ocular Events in Patients (Pts) Treated With Belantamab Mafodotin (Belamaf) Plus Bortezomib and Dexamethasone (BVd) in the DREAMM-7 Study by Hungria, Vania T.M., Robak, Pawel, Hus, Marek, Fu, Chengcheng, Zherebtsova, Vera, Ward, Christopher, Ho, P. Joy, Hájek, Roman, Kim, Kihyun, de Lacerda, Marcelo Pitombeira, Aparecida-Martinez, Gracia, Dimopoulos, Meletios, Cerchione, Claudio, Pirooz, Nick, McKeown, Astrid, Rogers, Rachel, Kazeem, Benga, Wang, Zhaohui, Baig, Hena, Eccersley, Lydia, Roy-Ghanta, Sumita, Opalinska, Joanna, Manteca, María-Victoria Mateos

Get full text

DREAMM-7 Update: Subgroup Analyses From a Phase 3 Trial of Belantamab Mafodotin (Belamaf) + Bortezomib and Dexamethasone (BVd) vs Daratumumab, Bortezomib, and Dexamethasone (DVd) in Relapsed/Refractory Multiple Myeloma (RRMM) by Mateos, Maria Victoria, Robak, Pawel, Hus, Marek, Fu, ChengCheng, Zherebtsova, Vera, Ward, Christopher, Joy Ho, P., Carolina de Almeida, Ana, Hajek, Roman, Kim, Kihyun, Dimopoulos, Meletios, Cerchione, Claudio, Pirooz, Nick, McKeown, Astrid, Kazeem, Benga, Baig, Hena, Eccersley, Lydia, Roy-Ghanta, Sumita, Opalinska, Joanna, Hungria, Vania

Get full text

MM-557 DREAMM-7 Update: Subgroup Analyses From a Phase 3 Trial of Belantamab Mafodotin (Belamaf) + Bortezomib and Dexamethasone (BVd) vs Daratumumab, Bortezomib, and Dexamethasone (DVd) in Relapsed/Refractory Multiple Myeloma (RRMM) by Victoria, Maria, Robak, Pawel, Hus, Marek, Fu, ChengCheng, Zherebtsova, Vera, Ward, Christopher, Ho, P. Joy, de Almeida, Ana Carolina, Hajek, Roman, Kim, Kihyun, Dimopoulos, Meletios, Cerchione, Claudio, Pirooz, Nick, McKeown, Astrid, Kazeem, Benga, Baig, Hena, Eccersley, Lydia, Roy-Ghanta, Sumita, Opalinska, Joanna, Hungria, Vania

“…Patients (pts) with RRMM and high-risk cytogenetics or disease refractory to major drug classes have an unmet need. In DREAMM-7 (NCT04246047), BVd demonstrated…”
Get full text